Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinri Group (Today's Group) is a diversified healthcare and pharmaceutical conglomerate founded in Hong Kong in 1979. The company operates a significant manufacturing and R&D base in Xiamen, China, through its subsidiary Jinri Pharmaceutical. It specializes in the production of active pharmaceutical ingredients (APIs), finished drug formulations, and a wide range of health supplements, including ginseng and donkey-hide gelatin. Jinri Group is a major player in the Chinese market for alpha-glucosidase inhibitors and traditional health products, leveraging a robust distribution network to serve both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Today's Group.